Cdc45 Limits Replicon Usage from a Low Density of preRCs in Mammalian Cells
Philip G. Wong(Molecular Oncology (United States)), Mark G. Alexandrow(Moffitt Cancer Center)
Cited by 97
Related Papers
Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function
|Molecular Cancer Therapeutics|2024|6